High Dose Cancer Therapy
Pharmacology, Hematopoietins, Stem Cells
Lippincott Williams and Wilkins (Publisher)
2nd Edition
Published on 1. January 1995
Book
Hardback
930 pages
978-0-683-00262-1 (ISBN)
Article exhausted; check for reprint
Description
This work addresses the issues of treating patients with cancer with higher doses of chemotherapy, whether supported by allogeneic bone marrow transplantation, growth factor support, or no extra treatment. Dose intensive therapy is one of the fastest growing and most promising areas of oncology. This text explores this modality for the broad range of malignancies practitioners are likely to encounter in practice.
This work addresses the issues of treating patients with cancer with higher doses of chemotherapy, whether supported by allogeneic bone marrow transplantation, growth factor support, or no extra treatment. Dose intensive therapy is one of the fastest growing and most promising areas of oncology. This text explores this modality for the broad range of malignancies practitioners are likely to encounter in practice.
This work addresses the issues of treating patients with cancer with higher doses of chemotherapy, whether supported by allogeneic bone marrow transplantation, growth factor support, or no extra treatment. Dose intensive therapy is one of the fastest growing and most promising areas of oncology. This text explores this modality for the broad range of malignancies practitioners are likely to encounter in practice.
More details
Edition
2nd Revised edition
Language
English
Place of publication
Philadelphia
United States
Target group
Professional and scholarly
Edition type
Revised edition
Illustrations
178 illustrations, index
Dimensions
Height: 260 mm
Weight
1777 gr
ISBN-13
978-0-683-00262-1 (9780683002621)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Other editions
New editions
Book
12/1999
3rd Edition
Lippincott Williams and Wilkins
€170.84
Article exhausted; check different version
Persons
Content
Strategies for the use of agents at high dose; re-establishing haematopoiesis after dose-intensive therapy; A - transplantation; B - marrow contamination; C - growth factors; laboratory and clinical support for dose-intensive therapy; clinical applications for high-dose therapy.